Read + Share
Amedeo Smart
Independent Medical Education
Pepperrell T, Venter WDF, McCann K, Bosch B, et al. Participants on dolutegravir re-suppress HIV RNA after virologic failure: updated data from the ADVANCE trial. Clin Infect Dis 2021 Feb 2. pii: 6126766. doi: 10.1093.PMID: 33530097
Email
LinkedIn
Facebook
Twitter
Privacy Policy